Lobe Sciences Ltd.
LOBEF
$0.08
-$0.01-6.21%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -166.17% | -12.75% | 31.59% | -123.53% | -10.85% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -135.14% | -263.46% | -83.65% | 68.11% | 145.93% |
| Change in Net Operating Assets | -237.59% | 234.07% | 307.05% | 191.07% | -66.72% |
| Cash from Operations | -488.39% | -134.69% | -2,694.23% | -22.85% | -1,001.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -3,793.58% | 2,364.48% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -97.51% | 2,288.46% | -- |
| Foreign Exchange rate Adjustments | 105.00% | -84.38% | -991.30% | 206.35% | -478.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -400,811.11% | 163.84% | -1,113.28% | 31,288.89% | 97.09% |